Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-009636
Filing Date
2025-05-12
Accepted
2025-05-12 14:34:24
Documents
58
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 614154
2 EX-31.1 ex31-1.htm EX-31.1 12541
3 EX-31.2 ex31-2.htm EX-31.2 12543
4 EX-32.1 ex32-1.htm EX-32.1 7611
5 EX-32.2 ex32-2.htm EX-32.2 7513
  Complete submission text file 0001641172-25-009636.txt   3962877

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE exoz-20250331.xsd EX-101.SCH 34825
7 XBRL CALCULATION FILE exoz-20250331_cal.xml EX-101.CAL 41797
8 XBRL DEFINITION FILE exoz-20250331_def.xml EX-101.DEF 143377
9 XBRL LABEL FILE exoz-20250331_lab.xml EX-101.LAB 294105
10 XBRL PRESENTATION FILE exoz-20250331_pre.xml EX-101.PRE 229305
60 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 504768
Mailing Address 750 ROYAL OAKS DR MONROVIA CA 91016
Business Address 750 ROYAL OAKS DR MONROVIA CA 91016 (626) - 415 - 1488
EXOZYMES INC. (Filer) CIK: 0002010788 (see all company filings)

EIN.: 834550057 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42204 | Film No.: 25934194
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)